Product Information
OLANZAPINE-FLUOXETINE 6-50 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.4489 per EA under NDC 00093550556. Its NADAC has been published 458 times since Nov 28, 2013.
Strength
50; 6 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093550556
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDE; OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077528On Market Since
6/19/2012
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE-FLUOXETINE 6-50 MG has been published 458 times since Nov 28, 2013, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4489 per EA |
|---|---|
| All-time high | $12.1647 (Jan 15, 2014) |
| All-time low | $4.4489 (Jun 17, 2026) |
| 52-week high | $5.5480 |
| 52-week low | $4.4489 |
| Median price | $7.8310 |
| Average price | $8.0557 |
| Largest weekly change | -27.5% (Dec 19, 2018) |
| Weeks tracked | 458 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Olanzapine and Fluoxetine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OLANZAPINE-FLUOXETINE 6-50 MG?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 6-50 MG, manufactured by Teva Pharmaceuticals USA Inc., is $4.4489 per EA (NDC 00093550556), effective Jun 24, 2026.
How has the price of OLANZAPINE-FLUOXETINE 6-50 MG changed over time?
Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 6-50 MG has declined 57.4%. It has been tracked across 458 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 6-50 MG?
Since Nov 28, 2013, the NADAC for OLANZAPINE-FLUOXETINE 6-50 MG has ranged from a low of $4.4489 (Jun 17, 2026) to a high of $12.1647 (Jan 15, 2014), with a median of $7.8310 per EA.
Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 6-50 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OLANZAPINE-FLUOXETINE 6-50 MG, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE-FLUOXETINE 6-50 MG?
OLANZAPINE-FLUOXETINE 6-50 MG (NDC 00093550556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification